HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

  • J9062

    Injection, amivantamab 5 mg and hyaluronidase-lpuj

  • J9063

    Injection, mirvetuximab soravtansine-gynx, 1 mg

  • J9064

    Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg

  • J9065

    Injection, cladribine, per 1 mg

  • J9070

    Cyclophosphamide, 100 mg

  • J9071

    Injection, cyclophosphamide (auromedics), 5 mg

  • J9072

    Injection, cyclophosphamide (frindovyx), 5 mg

  • J9073

    Injection, cyclophosphamide (dr. reddy's), 5 mg

  • J9074

    Injection, cyclophosphamide (sandoz), 5 mg

  • J9075

    Injection, cyclophosphamide, not otherwise specified, 5 mg

  • J9076

    Injection, cyclophosphamide (baxter), 5 mg

  • J9098

    Injection, cytarabine liposome, 10 mg

  • J9100

    Injection, cytarabine, 100 mg

  • J9118

    Injection, calaspargase pegol-mknl, 10 units

  • J9119

    Injection, cemiplimab-rwlc, 1 mg

  • J9120

    Injection, dactinomycin, 0.5 mg

  • J9130

    Dacarbazine, 100 mg

  • J9144

    Injection, daratumumab, 10 mg and hyaluronidase-fihj

  • J9145

    Injection, daratumumab, 10 mg

  • J9150

    Injection, daunorubicin, 10 mg

  • J9151

    Injection, daunorubicin citrate, liposomal formulation, 10 mg

  • J9153

    Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

  • J9155

    Injection, degarelix, 1 mg

  • J9160

    Injection, denileukin diftitox, 300 micrograms

  • J9161

    Injection, denileukin diftitox-cxdl, 1 mcg

  • J9165

    Injection, diethylstilbestrol diphosphate, 250 mg

  • J9171

    Injection, docetaxel, 1 mg

  • J9172

    Injection, docetaxel (docivyx), 1 mg

  • J9173

    Injection, durvalumab, 10 mg

  • J9174

    Injection, docetaxel (beizray), 1 mg

  • J9175

    Injection, elliotts' b solution, 1 ml

  • J9176

    Injection, elotuzumab, 1 mg

  • J9177

    Injection, enfortumab vedotin-ejfv, 0.25 mg

  • J9178

    Injection, epirubicin hcl, 2 mg

  • J9179

    Injection, eribulin mesylate, 0.1 mg

  • J9181

    Injection, etoposide, 10 mg

  • J9183

    Gemcitabine intravesical system, 225 mg

  • J9184

    Injection, gemcitabine hydrochloride (avyxa), 200 mg

  • J9185

    Injection, fludarabine phosphate, 50 mg

  • J9190

    Injection, fluorouracil, 500 mg

  • J9196

    Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

  • J9198

    Injection, gemcitabine hydrochloride, (infugem), 100 mg

  • J9199

    Injection, gemcitabine hydrochloride (infugem), 200 mg

  • J9200

    Injection, floxuridine, 500 mg

  • J9201

    Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

  • J9202

    Goserelin acetate implant, per 3.6 mg

  • J9203

    Injection, gemtuzumab ozogamicin, 0.1 mg

  • J9204

    Injection, mogamulizumab-kpkc, 1 mg

  • J9205

    Injection, irinotecan liposome, 1 mg

  • J9206

    Injection, irinotecan, 20 mg

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/22/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.